X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Targeted Oncology

期刊標題檢索 TARGET ONCOL 最新評論: The article about tumors is very easy, it will be hired in a minute (2023-07-18)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Targeted Oncology]您好,您是該頁面的第 35455 位訪客。

期刊簡介
期刊名稱Targeted Oncology Targeted Oncology
LetPub Score
7.3
50 ratings
Rate

Reputation
8.8

Influence
6.1

Speed
7.0

期刊簡稱TARGET ONCOL
ISSN1776-2596
E-ISSN1776-260X
h-index35
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.401.4210.949
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q132 / 272
Category: Medicine
Subcategory: Oncology
Q176 / 404
Category: Medicine
Subcategory: Cancer Research
Q269 / 230

自引率 (2023-2024)2.30%自引率趨勢
掲載範囲
Targeted Oncology addresses physicians and scientists committed to oncology and cancer research by providing a programme of articles on molecularly targeted pharmacotherapy in oncology. The journal includes:

Original Research Articles on all aspects of molecularly targeted agents for the treatment of cancer, including immune checkpoint inhibitors and related approaches.
Comprehensive narrative Review Articles and shorter Leading Articles discussing relevant clinically established as well as emerging agents and pathways.
Current Opinion articles that place interesting areas in perspective.
Therapy in Practice articles that provide a guide to the optimum management of a condition and highlight practical, clinically relevant considerations and recommendations.
Systematic Reviews that use explicit, systematic methods as outlined by the PRISMA statement.
Adis Drug Reviews of the properties and place in therapy of both newer and established targeted drugs in oncology.
官方網站https://www.springer.com/11523
在線稿件提交https://www.editorialmanager.com/targ
開放訪問No
出版商Springer International Publishing
主題領域医学
出版國/地區FRANCE
發行頻率四半期刊行
創刊年2006
每年文章數70每年文章數趨勢
黃金OA百分比51.26%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ286/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1776-2596%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【Targeted Oncology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS332211
    CANCER RESEARCH312202
    BMC CANCER245917
    Asian Pacific Journal of Cancer Prevention220892
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198023
    INTERNATIONAL JOURNAL OF CANCER191769
    CLINICAL CANCER RESEARCH181685
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY177243
    ONCOLOGY REPORTS175160
    CA-A CANCER JOURNAL FOR CLINICIANS163682
  •  

    Targeted Oncology Targeted Oncology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [Targeted Oncology] 的評論撰寫評論
作者: 混元新曦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-18 13:04:05 評論於
The article about tumors is very easy, it will be hired in a minute
(0) 讚! | 混元新曦

作者: 耀择来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-08 16:39:51 評論於
The requirements of this magazine are difficult to understand, as they request rejected peer review feedback and explanations. It's just too much, providing rejected peer review feedback will only result in being rejected again
(0) 讚! | 耀择来了

作者: 拈花怀青


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-22 10:54:06 評論於
May I ask how you are doing now?
(0) 讚! | 拈花怀青

作者: 龙鳞倩云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-08 20:13:15 評論於
Research focus: Cancer; Experience sharing on review: It has been 4 days since submission, and it has always been "new submission". I don't know what the situation is. Should I follow up?
(0) 讚! | 龙鳞倩云

作者: 龙鳞倩云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-07 20:32:27 評論於
Heavy research direction: Summary of shared experiences: It has been 4 days since submission, and it has always been 'new submission'. Does anyone have the same situation? Should I send a reminder?
(0) 讚! | 龙鳞倩云

作者: 岳家园园


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-31 21:04:00 評論於
Is it free? Is this a service?
(0) 讚! | 岳家园园

作者: 打狗瑞芝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-11 15:01:14 評論於
Can you tell me how long the status of "new submission" will last?
(0) 讚! | 打狗瑞芝

作者: 一条小醉霜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-05 12:09:34 評論於
What's going on now?
(0) 讚! | 一条小醉霜

作者: 五虎煜喆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-30 17:20:22 評論於
It's been ten days, still no new submission
(0) 讚! | 五虎煜喆

作者: 五虎煜喆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-27 08:56:24 評論於
It has been 7 days and I am still a new submission
(0) 讚! | 五虎煜喆

作者: 书生永寿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-05 17:39:26 評論於
I also submitted my work two days ago and it is still New Submission
(0) 讚! | 书生永寿

作者: Baron Jonah


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-25 22:02:16 評論於
Do you want the raw data?
(0) 讚! | Baron Jonah

作者: 奇正小可爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-12 17:53:59 評論於
Bro, how are you doing?
(0) 讚! | 奇正小可爱

作者: 奇正小可爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-09 08:10:18 評論於
Brother, have you voted?
(0) 讚! | 奇正小可爱

作者: 五轮艺天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-10 12:41:36 評論於
Is the review process fast?
(0) 讚! | 五轮艺天

作者: 五轮艺天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-14 17:13:35 評論於
How many days does it take for the submission to reach the editor's hands?
(0) 讚! | 五轮艺天

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:27:56 評論於
Abstracts include some common key parts, each part consisting of about one to two sentences, such as background, aim or purpose of research, method used, findings/results, and conclusion
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:26:35 評論於
The research objective describes the research background and explains why this study is being conducted. It is a necessary element for writing an abstract
(0) 讚! | 维尔娜菲茨杰拉德

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 20:01:40 評論於
Do we have to include the research objectives in the abstract?
(0) 讚! | 深渊兴业

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 16:08:08 評論於
How to write an abstract? Is there a template?
(0) 讚! | 北国博达

作者: 中原红螺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-29 22:16:04 評論於
When will your submission be delivered to the editor's hands?
(0) 讚! | 中原红螺

作者: Bruce Nicholas


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-03-06 14:37:30 評論於
Is anyone reviewing submissions? Why is my submission still showing as "New Submission" after several days?
(0) 讚! | Bruce Nicholas

作者: 白云庚辰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-02-20 21:07:10 評論於
In the "corresponding author" section of the TARGETED ONCOLOGY Conflict of Interest disclosure form, should I indicate whether or not there is a conflict of interest, or should I provide the name of the corresponding author?
(0) 讚! | 白云庚辰

作者: 中原子超


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-11-21 19:18:37 評論於
Hello, are the magazines recommended by them all included in SCI?
(0) 讚! | 中原子超

作者: 中原子超


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-11-21 11:10:09 評論於
Are the magazines recommended by them the same as those included in SCI?
(0) 讚! | 中原子超

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [Targeted Oncology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*